Spravato® (esketamine) is a newer pharmaceutical that was approved by the United States Food and Drug Administration (FDA) in 2019, to be delivered in a clinical setting as a nasal spray along with an oral antidepressant. As a depression medication,…
Andrew SchatzbergApril 7, 2023